federal_register: 04-9324
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-9324 | Guidance for Industry on Changes to an Approved New Drug Application or Abbreviated New Drug Application; Availability; Correction | Notice | The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of April 8, 2004 (69 FR 18768). The document announced the availability of a revised guidance for industry entitled "Changes to an Approved NDA or ANDA." The document was published with inadvertent errors. This document corrects those errors. | 2004-04-26 | 2004 | 4 | https://www.federalregister.gov/documents/2004/04/26/04-9324/guidance-for-industry-on-changes-to-an-approved-new-drug-application-or-abbreviated-new-drug | https://www.govinfo.gov/content/pkg/FR-2004-04-26/pdf/04-9324.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of April 8, 2004 (69 FR 18768). The document announced the availability of a revised guidance for industry entitled "Changes to an Approved NDA or... |